An Alprazolam E-Prescription From an Expired DEA Registration
A 41-year-old man presents a printed electronic prescription for alprazolam 2 mg, #90, one tablet three times daily, from a physician 70 miles away. The prescription is dated today and the patient is paying cash. The pharmacist checks the prescriber’s DEA registration in the pharmacy system and finds it expired 12 days ago; the state license is active. The patient says he is new to Delaware and his previous pharmacy closed. The Delaware PMP shows fills of alprazolam 2 mg #90 and oxycodone 10 mg #60 from two different prescribers and two pharmacies in the past 45 days. The patient is drowsy and has slurred speech. The prescriber’s office is open and a staff member says the doctor “will renew the DEA soon” and asks the pharmacist to fill it anyway.
1. May the pharmacist fill the alprazolam prescription? Explain the legal basis.
Read the worked answer
No. A prescriber must have a valid DEA registration to prescribe a controlled substance. An expired DEA registration means the prescriber lacks federal authority to issue the prescription, regardless of the active state license or the office’s assurance that renewal is pending. The pharmacist cannot rely on a promise of future registration; the registration must be active on the date the prescription is issued and dispensed. The pharmacy’s own verification record showing expiration is sufficient reason to refuse.
The refusal is also supported by corresponding responsibility. The prescription is cash-paid, comes from a prescriber 70 miles away, and the PMP shows recent alprazolam and oxycodone from different prescribers and pharmacies. The patient is drowsy and slurring speech, which raises concern about sedation and possible duplicative prescribing. The pharmacist should not fill the prescription even if the office offers verbal confirmation. The pharmacist should explain to the patient that the prescription cannot be filled because the prescriber’s registration is not active and that the prescriber must resolve the registration issue and issue a new prescription after it is active. The pharmacist should not dispense a partial supply or “hold” the prescription indefinitely.
2. What should the pharmacist document and report, and how should the patient’s apparent impairment be handled?
Read the worked answer
The pharmacist should document the prescription details, the DEA registration check and its expiration date, the PMP review, the patient’s statements, the office call, and the specific reason for refusal. The documentation should be factual and objective, avoiding conclusions about the patient’s character. The pharmacist should notify the prescriber’s office in writing or by a documented phone call that the prescription was not filled because the DEA registration was expired. If the pharmacist suspects fraud, forgery, or diversion, the pharmacist should report the matter to the Delaware Board of Pharmacy and to DEA under the applicable suspicious-order or suspicious-prescription reporting framework; Delaware’s controlled-substance authorities also expect such concerns to be documented.
Because the patient appears drowsy and has slurred speech, the pharmacist should not simply send him away to drive. The pharmacist should keep the interaction calm, avoid dispensing any controlled substance, and consider calling emergency services if the patient cannot safely leave or appears markedly sedated. The pharmacist can offer naloxone education if opioid involvement is suspected, provide information about local treatment resources, and document the safety intervention. The pharmacist should retain the prescription or a copy according to pharmacy policy and applicable recordkeeping rules, and should not return a potentially forged prescription without guidance from the Board or law enforcement.